Showing results (861-870 of 902) with videos related to
Sort By:
Pageof 91
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
Metastatic colon cancer, version 3.2013: featured updates to the NCCN GuidelinesAl B Benson, Tanios Bekaii-Saab, Emily Chan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Lynette Cederquist, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2018
NCCN Guidelines Insights: Colon Cancer, Version 2.2018Al B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.Nature Medicine|October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockadeEmily C Harrold, Michael B Foote, Benoit Rousseau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal CancerNeil H Segal, Andrea Cercek, Geoffrey Ku, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Rectal Cancer, Version 2.2015Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.JAMA Oncology|November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialAndrea Cercek, Thomas Boerner, Benjamin R Tan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 13, 2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018Manisha H Shah, Whitney S Goldner, Thorvardur R Halfdanarson, et al.Pageof 91